Efficacy and safety of the long-acting C5 inhibitor ravulizumab in patients with atypical hemolytic uremic syndrome triggered by pregnancy: a subgroup analysis
| Image |  |
|---|---|
| Description | scientific article published on 06 January 2021 |
| Author/s |
author: Ulf Schönermarck |
| Publication date | January 6, 2021 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |